Skip to content
Gilenya Label Change - Monitor for Heart Problems
Elizabeth_WebMD_Staff posted:
The drug-maker, Novartis, said it has agreed with USDA to change labels on Gilenya to include recommendations for patients to be closely monitored for heart problems.

New Warnings for MS Drug Gilenya After FDA Review

In addition to cosely monitoring for macular edema, those taking the drug for the first time will require an EKG followed by hourly blood pressure and heart rate checks for the first six hours, then a follow-up EKG.

Share your experience with Gilenya. Will this label change prompt you to contact your doctor?

Do you know how to report adverse reactions? Contact MedWatch website or call 1-800-FDA-1088.


Featuring Experts

Stephanie knows multiple sclerosis as a patient and as a nurse. Stephanie was diagnosed with multiple sclerosis in 2013. Shortly after being diagnosed...More

Helpful Tips

Help Our Community & Experts Help You - Please Read
Welcome to the WebMD Multiple Sclerosis Community! Please don't respond to this discussion. Instead, please read before you start your ... More
Was this Helpful?
107 of 109 found this helpful

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.